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ABSTRACT   
Obesity is strongly associated with insulin resistance, hyperglycemia, and hyperlipidemia, 
which are also linked to mitochondrial dysfunction and increased production of reactive 
oxygen species (ROS). Foods such as wheat germ (WG), which is rich in antioxidants, are 
thought to protect tissues from damage due to ROS and modulate some negative effects of 
obesity. This study examined the effects of WG supplementation on body composition, 
insulin resistance markers, and mitochondrial function in the liver and heart. Six-week-old 
male C57BL/6 mice were randomized into four dietary treatment groups (n=12 mice/group): 
control (C, 55% fat kcal), control + 10% WG (C+WG), high fat (HF, 55% fat kcal), or 
HF+WG. After 90 days of treatment, HF+WG mice had significantly less visceral fat and 
less insulin resistant compared to the HF group. Addition of WG to the control diet showed 
no considerable effect. HF feeding compared to control significantly elevated (p<0.05) 
cardiac oxygen consumption in complex 2, while WG supplementation to the HF diet 
stabilized this effect to the level of control. Consequently, Sod2 and Pgc1a genes which 
mediate antioxidant defense and mitochondrial biogenesis respectively, were significantly 
reduced (p<0.05) in the heart of the HF group compared to control while WG 
supplementation tended to upregulate both genes. These effects of WG were not observed in 
the liver. Put together, these results showed that WG supplementation in HF diet reduced 
insulin resistance and improved the metabolic functions of the cardiac mitochondria.  
1. Introduction 
Obesity is a major public health problem worldwide. Data from the World Health 
Organization (WHO) showed that in 2014, nearly 2 billion people globally were overweight 
or obese (World Health Organization, 2016). Obesity is strongly associated with insulin 
resistance, hyperinsulinemia, hyperglycemia, and hyperlipidemia, which are all key 
components of type 2 diabetes (T2D) (LeRoith et al, 2008).  
The mitochondria generate ATP by oxidation-reduction reaction using the electron 
carriers NADH or FADH2. Electrons obtained from the oxidation of metabolic fuels are 







molecular oxygen, which is ultimately converted to water (Rolo et al, 2006). However, even 
in normal metabolism some oxygen (approximately 0.1%) leaks from the respiratory chain 
resulting in incompletely reduced oxygen molecules, or ROS, such as superoxide, which can 
damage the mitochondria and cell (Rolo et al, 2006). Mitochondrial function can be assessed 
in multiple ways, including changes in mtDNA encoded genes, altered expression or activity 
of enzymes involved in oxidative phosphorylation, and mitochondrial oxygen consumption 
rates (OCR) in response to various challenges (Montgomery, et al 2015). Mitochondrial 
function may be affected by a variety of factors including genetics, oxidative stress, diet, 
mitochondrial biogenesis, and aging (Kim et al, 2008). 
Apart from stimulating insulin resistance and T2D, high fat (HF) diet-induced obesity 
has been shown to induce mitochondrial dysfunction and reactive oxygen species (ROS) 
generation, while modulating significant changes in fuel metabolism in the heart and the liver 
(Cole et al, 2011; Lim et al, 2014; Vial et al, 2010). At the genetic level, the mitochondrial 
master-regulator gene PGC-1a, as well as genes induced by PGC-1a, is downregulated in 
humans with T2D (Mootha et al, 2006). Moreover, Sreekumar et al (2002), reported lower 
gene expression levels of the antioxidant enzyme, superoxide dismutase (SOD-1 and SOD-2) 
in the skeletal muscle of rats fed a HF diet compared to rats fed a low fat diet, suggesting a 
loss of ability to cope with ROS generation. Therefore, it is vital to maintain the body’s 
natural antioxidant enzymes levels in order to combat increased ROS production as a result 
of HF diet-induced mitochondrial dysfunction. 
 Considering the increased prevalence of obesity and its related morbidities such as 
T2D, studies that investigate approaches and mechanisms to alleviate obesity-related T2D, 
oxidative stress, and mitochondrial dysfunction are needed. Wheat germ (WG) contains 
relatively large amounts of bioactive compounds known to have antioxidant properties such 
as tocopherols, carotenoids, flavonoids, and phytosterols (Cara et al, 1992). Traditionally, 
WG has been mostly ignored as a byproduct of wheat milling. When utilized, WG is most 
frequently used to produce WG oil or to add bulk to livestock feed (Brandolini et al, 2012). A 
previous study found a significant decrease in CD40 ligand, a protein with pro-inflammatory 
qualities, in patients with hypercholesterolemia who consumed a WG oil supplement for two 
months (Alessandri et al, 2006). Similarly, Cara, et al. (1992) reported that subjects with 
hypercholesterolemia and hypertriglyceridemia who supplemented their diets with WG had 
lower plasma cholesterol, VLDL cholesterol, LDL cholesterol, and plasma triglyceride levels 
after 4-14 weeks (Cara et al, 1992). WG’s richness in antioxidant and bioactive compounds 
makes it a potentially useful natural food substance, which may play a role in preventing the 
oxidative damage to cells and mitochondrial dysfunction in obesity. However, there are no 
studies looking specifically at the effect of WG supplementation in a model of HF diet- 
induced obesity on oxidative stress and mitochondrial function. Therefore, the purpose of 
this study is to investigate the effects of WG supplementation on insulin resistance, 







fed a HF diet. We hypothesized that the bioactive compounds in WG will work in synergy to 
preserve mitochondrial function and reduce oxidative stress in HF diet-induced obese mice. 
2. Experimental Details 
Study design 
Forty-eight, six-week-old male C57BL/6 (Charles River Laboratory) mice were 
housed in groups of four at the Oklahoma State University (OSU) Laboratory Animal 
Research facility in a temperature- and humidity-controlled environment and maintained on a 
12 hr light:dark cycle with ad libitum access to deionized water. Mice were randomly 
assigned to four dietary treatment groups (n=12 mice/group: control (C, AIN-93M), C + 10% 
WG, high fat (HF), HF + 10% WG for 90 days (Appendix 1). WG were obtained from 
Shawnee Milling Co (Shawnee, OK), analyzed for its nutrient composition at NP Analytical 
Laboratories, (St Louis, MO) and added to the control or HF diets at a 10% wt/wt 
composition. The WG diets were adjusted to have the same macronutrient composition to the 
control and HF diets. Body weights were measured weekly and food intake was recorded 3 
times/wk. After 90 days of dietary treatment, mice were fasted for 4 hrs and anesthetized 
with a mixture of ketamine/xylazine followed by exsanguination. The Institutional Animal 
Care and Use Committee at OSU approved all animal handling and procedures.  
Glucose Tolerance Test (GTT) 
After 90 days of treatment, mice were fasted for 6 h before undergoing a glucose 
tolerance test. Mice were given an intravenous injection of a 20% glucose solution (2 g 
glucose/kg body weight). Blood glucose levels from tail blood were recorded 0, 15, 30, 60, 
and 120 minutes after glucose injection using an AlphaTrak glucometer (Abbott 
Laboratories). 
PCR Array and qPCR 
Total RNA was isolated from approximately 100 mg whole liver or 50 mg whole 
heart sample using Trizol reagent (Thermo Fischer Scientific, Middletown, VA). RNA 
concentration and integrity were measured using a Nanodrop spectrophotometer (Thermo 
Fischer Scientific, Middletown, VA) and agarose gel electrophoresis. cDNA was synthesized 
using SuperScript II (Invitrogen, Grand Island, NY). The cDNA from the individual samples 
was used as a template for PCR according to the protocol for using SYBR green chemistry 
on an ABI 7900HT system (Applied Biosystems, Grand Island, NY). Primers were designed 
using Primer Express v. 2.0 (Applied Biosystems) as described in Davis, et al (Davis et al, 
2012). Relative quantitation for each gene was determined using the 2-ΔΔCT method (Applied 
Biosystems User Bulletin #2) with Cyclophilin B (Cyclo) as the invariant control. Primer 
sequences used in these experiments are listed in Appendix 2.  
Plasma Measurements 
Plasma lipids, inflammatory markers, and diabetes markers were assessed as we have 
previously described (Ojo et al, 2016). Briefly, plasma concentrations of triglycerides (TGs), 







measured using a BioLis 24i automated analyzer (Carolina Chemistry). Using the Bio-Plex 
MAGPIX Multiplex Reader (Bio-Rad Laboratories Inc, CA), plasma diabetes markers 
(gastric inhibitory peptide [GIP], glucagon-like peptide 1 [GLP1], insulin, leptin, 
plasminogen activator inhibitor 1, and resistin) were assessed according to the 
manufacturer’s instructions. Insulin resistance was estimated utilizing the homeostatic model 
assessment of insulin resistance (HOMA-IR) (Matthews et al, 1985) HOMA-IR = (fasting 
insulin (μU/mL) x fasting glucose (mmol/L))/22.5. 
Seahorse Mitochondrial Flux Analyses 
Freshly obtained liver and heart ventricle (60 mg) were homogenized on ice at low 
speed (Qiagen homogenizer) in 0.5 mL of mitochondrial isolation buffer (210 mM mannitol, 
70 mM sucrose, 5 Mm HEPES,I mM EGTA and 0.5% (w/v) fatty acid-free BSA, pH 7.2), 
followed by a series of centrifugation steps as described earlier (Bharadwaj et al. 2015). 
Isolated mitochondria pellets were suspended in mitochondrial assay solution (1X MAS, 70 
mM sucrose, 220 mM mannitol, 5 mM MgCl2, 2 mM HEPES, 10 mM KH2PO4, 1 mM 
EGTA, 0.2% (w/v) fatty acid-free BSA) and protein concentration determined using Pierce 
BCA protein assay kit (ThermoScientific, Rockford, IL). Mitochondrial sample was re-
suspended in 200 µg/mL for further analyses. Mitochondrial respiration was measured as 
oxygen consumption rates (OCR) using the Seahorse XF 96 flux analyzer (Seahorse 
Bioscience, Billerica, MA) following manufacturer’s instructions. Briefly, isolated 
mitochondria from the liver and heart were seeded into a 96-well microplate at 4 ug/well and 
1 ug/well, respectively. For the coupling assay, final concentrations of compounds after port 
injections were 4 mM ADP (port A), 1.5 µM oligomycin (port B), 4 µM FCCP (port C) and 
4 µM antimycin A (port D). Final concentrations of compounds for the electron flow assay 
were 2 µM rotenone (port A), 10 mM succinate (port B), 4 µM antimycin A (port C) and 10 
mM/100 µM ascorbate/TMP (port D). From these reactions, basal respiration, proton leak, 
maximal respiratory capacity, complex 1, 2, 4, and 5 OCR were calculated using the adjusted 
method from previous study (Lay et al. 2016) and as illustrated in Appendix 3. Results are 
reported as pmol O2 min
-1 µg-1 protein. 
Statistical Analysis 
All data are reported as means±SEM. Differences between treatment groups were 
analyzed using one-way ANOVA followed by post hoc Tukey test using SAS 9.4 software. 
P-value < 0.05 was considered statistically significant.  
3. Results 
WG supplementation decreased amount of visceral fat but did not affect total body weight 
There were no differences in body weight between the 4 groups before treatment 
began. After 90 days of treatment, the mice in the HF group weighed significantly more than 
mice in the C group and C+WG mice weighed significantly more than C group mice (Fig. 
1A). There was no difference in the final weights of the mice in the HF group compared to 







yet weighed significantly more at the end of the experiment (Fig. 1A and 1B). Notably, mice 
in the HF and HF+WG groups had lower caloric intake than mice in the C and C+WG groups 
throughout the 90-day experimental period (Fig. 1B). The livers of mice in the HF and 
HF+WG groups weighed significantly less than the livers of the C and C+WG mice (Fig. 1C). 
However, mice in the C group have significantly less visceral fat compared to mice in the HF 
group (Fig. 1C). Mice that consumed the HF+WG diet also had significantly less visceral fat 
than mice in the HF group (Fig. 1C). HF and HF+WG mice had significantly less lean mass 
and significantly more fat mass compared to C and C+WG groups (Fig. 1C).  
Figure 1. Weekly body weights, food intake, and body composition of C57BL/6 mice fed 
either a control (C) or high fat (HF) diet supplemented with 10% WG for 90 days. 
 
n=12/group; Different letters indicate significant (P<0.05) difference between groups; Data = mean ± SE 
* C is different from HF and HF + WG; # C + WG is different from HF and HF + WG ; † C + WG is different from HF ;  
◊ C is different from C + WG; $ C is different from HF + WG 
WG supplementation improved GTT, fasting plasma insulin levels, and IR measurements 
HF and HF+WG mice had significantly higher blood glucose levels at baseline than C 
and C+WG mice (Fig. 2A). Two hours post-glucose injection, HF+WG mice had 
significantly lower (18.5%) glucose levels than HF mice. However, the GTT total area under 
the curve (tAUC) was not different between HF and HF+WG groups (Fig. 2B). Fasting 
plasma insulin levels were 2.3 fold lower in HF+WG mice than HF mice (1054 pg/mL 
compared to 2407 pg/mL, respectively). Gastric inhibitory polypeptide (GIP) was lower in 
the C+WG group compared to the C group. There were no differences in GIP expression 
between HF and HF+WG mice (Fig. 2D). Glucagon-like peptide-1 (GLP1) levels were not 
different across any of the groups (Fig. 2E). Insulin resistance, assessed by HOMA-IR, was 













Figure 2: Diabetes markers in C57BL/6 mice fed either a control (C) or high Fat (HF) diet 
supplemented with 10% WG for 90 days. 
 
n=10-12/group; Different letters indicate significant (P<0.05) difference between groups; Data = mean ± SE 
* C is different from HF and HF + WG; # C + WG is different from HF and HF + WG 
† C + WG is different from HF; ◊ C is different from C + WG; ∆ HF is different from HF + WG 
WG supplementation reduced OCR in complex 2 of the heart mitochondria 
Mitochondrial basal respiration rate in the liver was lowest in the C group while 
HF+WG mice consumed the most oxygen (Fig. 3A). Apart from this, other measured 
components in the liver mitochondria were not different (Fig. 3A). In the heart, HF+WG 
group significantly lowered OCR in complex 1 compared to the C group (p=0.0285), but 
there were no differences between C and C+WG or between HF and HF+WG (Fig. 3B). In 
complex 2 of the heart mitochondria, OCR was 32% higher (p<0.05) in HF mice compared 
to all the other groups (Fig. 3B). HF feeding significantly reduced complex 5 OCR compared 
to C group mice, while the addition of WG to either C or HF diet had no significant effect 
(Fig. 3B).  
Addition of WG to diets has modest effects on plasma lipids 
Plasma triglyceride levels were significantly higher (p=0.0061) in HF diet mice 
compared to C diet mice (Fig. 4A). Addition of WG to the C has no effect on plasma 
triglycerides but tended (P=0.14) to be lower when added to the HF (Fig. 4A). Non-esterified 
fatty acid (NEFA) levels were higher in C+WG mice compared to C mice (Fig. 4B). NEFA 
levels were not different between HF and HF+WG mice (Fig. 4B). Total plasma cholesterol 







There were no differences in cholesterol levels 
between C and C+WG mice. Plasma HDL 
levels were not different between C and C+WG 
or HF and HF+WG mice (Fig. 4D). 
 
HF diet fed mice showed reduced expression of 
the mitochondrial biogenesis marker, Pgc1a 
and the antioxidant enzyme, Sod2 in the heart 
Heart PGC1α was expressed 40% less in 
C+WG mice compared to C mice. Interestingly, 
PGC1α tended (P=0.16) to be expressed more 
highly in HF+WG mice compared to the HF 
mice (Fig. 5B). A 45% decrease (p=0.028) in 
Sod2 expression was observed in the heart of 
HF fed mice compared to C. Sod2 in the heart 
also tended (P=0.11) to be more highly 
expressed in the HF+WG group compared to 
the HF mice (Fig. 5B). No liver genes tested 
showed significant differences in expression 
(Fig 5A). 
4. Discussion and Conclusions 
The aim of the current study was to examine the 
effects of WG supplementation on insulin 
resistance, oxidative stress, and mitochondrial 
function in C57BL/6 in mice fed a high-fat diet for 90 
days. Mice fed a HF+WG diet demonstrated reduced 
visceral fat storage and insulin resistance compared to 
HF-diet fed mice. Results from a mitochondrial 
extracellular flux assay indicated increased oxygen 
consumption in complex II of HF-diet mice’s hearts, 
but without any change in activity of complex V, 
which is responsible for ATP synthesis. HF-diet fed 
mice also demonstrated decreased expression of Sod2 
compared to C and HF+WG fed mice indicating a 
reduced ability to cope with ROS and oxidative stress 
generated by an inefficient mitochondria. 
Figure 3: Mitochondrial oxygen consumption 
rates (OCR) in the liver and heart of C57BL/6 
mice fed either a control (C) or high fat (HF) diet 
supplemented with 10% WG for 90 days 
Figure 4: Plasma lipid content of C57BL/6 
mice fed either a control (C) or high fat (HF) 
diet supplemented with 10% WG for 90 days 
N=5/group; Different letters indicate 
significant (P<0.05) between groups; 
Data = mean ± SE  
 
N=12/group; Different letters indicate significance between groups | 








HF and HF+WG mice consumed 
significantly fewer kcal than C and 
C+WG mice, but the HF diet-based 
groups weighed significantly more than 
the C and C+WG mice from week 2 of 
the experiment onward. This suggests the 
fat content of the HF diet contributes 
more to weight gain than simply the 
number of calories consumed. Our 
finding that visceral fat accumulation was 
reduced in HF+WG mice compared to HF 
mice agreed with the findings of Palmieri 
et al. (2006) who demonstrated that lower 
levels of antioxidants were strongly 
associated with abdominal fat storage due 
to systemic oxidative stress. The same 
study found an inverse relationship 
between vitamin E consumption and 
visceral fat accumulations. Since WG is 
high in vitamin E (Cara et al, 1992), this 
may have contributed to the reduction in 
abdominal fat storage in HF+WG mice.  
HF+WG mice in this study demonstrated increased insulin sensitivity compared to HF 
mice, indicating that the addition of WG may modulate insulin resistance induced by a HF 
diet. GIP, which is thought to induce insulin secretion (Brubaker et al, 2002), was reduced by 
the addition of WG to both the C (P= 0.01 ) and HF (P= 0.07) diet, further suggesting WG 
supplementation increased insulin sensitivity. WG supplementation also improved the 
efficiency of mitochondrial complex II in the heart as the mitochondria isolated from mice on 
the HF+WG diet consumed less oxygen at complex II than mice from the HF diet. Although 
the OCR of complex II in HF-diet mice was significantly higher than other groups, this did 
not reflect in complex V OCR. Therefore, it is probable that in the HF group, electrons 
generated by oxygen consumption in complex II were not passed farther down the electron 
transport chain to complex V, which is the site of ATP synthesis. These lost electrons may 
have generated ROS within the heart mitochondria. Consequently, we noted significantly 
lower transcription of Sod2 in HF diet mice compared to C diet mice indicating an inability 
of the heart in mice fed HF diet to cope with increased ROS production. Although not 
significant, Sod2 expression tended to be higher in the hearts of HF+WG mice compared to 
HF mice suggesting that WG supplementation may have the potential of sustaining the 
ability of heart cells to cope with ROS generation. 
Figure 5: Relative gene expression of mitochondrial 
biogenesis and oxidative stress markers in C57BL/6 
mice fed either a control (C) or high fat (HF) diet 
supplemented with 10% WG for 90 days 
N=6/group ; Different letters indicate significance between 








There are limited animal and clinical studies that have investigated the health benefits of 
WG and its oil, but previous studies have provided evidence for wheat germ or wheat germ 
oil improving the response to oxidative stress. One study by Alessandri, et al. found that 
hypercholesterolemic patients who consumed a WG oil supplement showed reduced markers 
of oxidative stress, but did not have lower cholesterol levels. Our results, however, showed an 
increase in total plasma cholesterol levels in the HF+WG mice compared to HF diet mice 
suggesting that while wheat germ or wheat germ oil may be beneficial in reducing oxidative 
stress it may or may not actually lower cholesterol levels (Alessandri et al, 2006). The effects 
of WG on lipid metabolism need to be further investigated. Expression of Pgc1α was 
decreased in the hearts of C+WG fed mice compared to C mice. Pgc1α is known as the 
mitochondrial biogenesis master regulator and its decreased expression in C+WG mice 
suggests that WG supplementation may lower oxidative stress enough to reduce the need for 
mitochondrial biogenesis and production of new mitochondria to replace damaged ones.  
A limitation of this study may be the possibility of achieving the 10% WG dose in 
humans. In a 70 kg adult, 10% wheat germ consumption per day would equate to about 50 g 
of wheat germ per day. At this time, it is not clear if a lower dose would create the same 
effects.  Therefore, future studies may investigate the dose-dependent effects of WG 
supplementation in a model of diet-induced obesity. Nevertheless, the findings of this study 
indicate supplementing a HF diet with WG may increase the ability of C57BL/6 mice’s 
hearts to cope with oxidative stress and other damage induced by HF diet, including 
additional visceral fat accumulation, increased insulin resistance, likely increased generation 
of ROS by inefficient mitochondria, and decreased innate antioxidant ability to cope with 
ROS. 
4. Summary 
WG is rich in antioxidants that may protect cells from the oxidative stress induced-
damage due to a high fat diet. Since the mitochondria is a master regulator of ROS 
production, this study investigated the effects of WG supplementation on hepatic and cardiac 
mitochondrial function and innate antioxidant defense in C57BL/6 mice fed either a control 
or HF diet for 90 days. In this study, addition of WG to a diet high in fat tended to increase 
the ability of the heart to cope with oxidative stress by up regulating expression of Sod2 
compared to HF fed mice alone. WG supplementation also decreased visceral fat 
accumulation, decreased insulin resistance, and stabilized complex 2 oxygen consumption 
rate in the heart to the level of control. This study showed that supplementing a HF diet with 
WG has the potential to mitigate the negative effects of HF diet-induced obesity on insulin 











Appendix 1: Diet Composition (g/kg diet) for control (C), high fat (HF), control + wheat 













 C HF C+WG HF+WG 
Wheat Germ -- -- 100 100 
Carbohydrates     
Total 722.1 372.26 724.77 374.93 
Cornstarch 466 0 412.9 0 
Sucrose 100 270 100 270 
Dextrinized Cornstarch 155 100 155 46.9 
WG -- -- 53.1 53.1 
Protein     
Total 140 180 140 180 
Casein 140 180 116.6 156.6 
WG -- -- 23.4 23.4 
Fat     
Total 40 350 40 350 
Soybean Oil 40 40 33.35 33.35 
Lard 0 310 0 310 
WG -- -- 6.65 6.65 
Fiber     
Total 50 50 50 50 
Cellulose 50 50 45.84 45.84 
WG -- -- 4.16 4.16 
Vitamin Mix 10 10 10 10 
Mineral Mix     
Total 35 35 35 35 
Calcium 25.9 25.9 25.7 25.7 
Calcium from WG -- -- 0.06 0.06 
Sodium Phosphate 5.6 4.8 3.8 3.02 
Potassium Phosphate 2.4 2.06 1.65 1.3 
Phosphorous from WG -- -- 0.8 0.8 







Appendix 2: PCR Primers 
Target gene Primer Sequence 
Pgc1α F 5’ AAC-CAC-ACC-CAC-AGG-ATC-AGA 3’ 
R 5’ TCT-TCG-CTT-TAT-TGC-TCC-ATG-A 3’ 
Pgc1β F 5’ GAG-GGC-TCC-GGC-ACT-TC 3’ 
R 5’ CGT-ACT-TGC-TTT-TCC-CAG-ATG-A 3’ 
Sod1 F 5’ GCC-CGG-CGG-ATG-AAG-A 3’ 
R 5’ CGT-CCT-TTC-CAG-CAG-TCA-CA 3’ 
Sod2 F 5’ CTC-TGG-CCA-AGG-GGA-GAT-GTT 3’ 
R 5’ GTC-CCC-CAC-CAT-TGA-ACT-TC 3’ 
Sod3 F 5’ CAG-ACA-AAG-GAG-CGC-AAG-AAG 3’ 
R 5’ TGA-GGC-TTA-AGT-GGT-CTT-GCA 3’ 
Appendix 3: Seahorse Mitochondria Analysis Graphs 
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